|
⚲
|
| Keyboard |
| Markham Richard J
✚
|
|
|---|---|
| CIK # | 0001362743 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001362743] | |
| 4 | [0001362743] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2019-06-12 | Grant | 12,700 | $0.00 | |
|
NABI Biopharmaceuticals VXRT
Stock Option (right to buy) · derivative
|
2019-06-12 | Grant | 9,000 | $0.00 | |
|
NABI Biopharmaceuticals AVIR
Common Stock
|
2018-02-13 | Grant | 30,793,670 | ||
|
CoLucid Pharmaceuticals Inc CLCD
Series C Convertible Preferred Stock · derivative
|
2015-05-11 | Conversion | 320,295 | $0.00 | |
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2015-05-11 | Conversion | 25,403 | ||
|
CoLucid Pharmaceuticals Inc CLCD
Common Stock
|
2015-05-11 | Conversion | 1,520,136 | ||
|
CoLucid Pharmaceuticals Inc CLCD
Series C Convertible Preferred Stock · derivative
|
2015-05-11 | Conversion | 5,353 | $0.00 | |
|
CoLucid Pharmaceuticals Inc CLCD
Series B Convertible Preferred Stock · derivative
|
2015-05-11 | Conversion | 1,199,841 | $0.00 | |
|
CoLucid Pharmaceuticals Inc CLCD
Series B Convertible Preferred Stock · derivative
|
2015-05-11 | Conversion | 20,050 | $0.00 | |
|
CoLucid Pharmaceuticals Inc CLCD
Stock Option (Right to Buy) · derivative
|
2015-05-05 | Grant | 5,954 | $0.00 | |
|
NephroGenex Inc NRX
Options to Purchase Common Stock · derivative
|
2015-04-30 | Grant | 6,870 | $0.00 | |
|
CoLucid Pharmaceuticals Inc CLCD
Series B Convertible Preferred Stock · derivative
|
2015-01-12 | Buy | 16,041 | $0.00 | |
|
CoLucid Pharmaceuticals Inc CLCD
Series C Convertible Preferred Stock · derivative
|
2015-01-12 | Buy | 320,295 | $0.00 | |
|
CoLucid Pharmaceuticals Inc CLCD
Series C Convertible Preferred Stock · derivative
|
2015-01-12 | Buy | 5,353 | $0.00 | |
|
CoLucid Pharmaceuticals Inc CLCD
Series B Convertible Preferred Stock · derivative
|
2015-01-12 | Buy | 959,872 | $0.00 | |
|
NephroGenex Inc NRX
Options to Purchase Common Stock · derivative
|
2014-05-15 | Grant | 3,076 | $0.00 | |
|
NephroGenex Inc NRX
Series A Preferred Stock · derivative
|
2014-02-14 | Conversion | 5,785,962 | ||
|
NephroGenex Inc NRX
Series A Preferred Stock · derivative
|
2014-02-14 | Conversion | 13,964,398 | ||
|
NephroGenex Inc NRX
Series A Preferred Stock · derivative
|
2014-02-14 | Conversion | |||
|
NephroGenex Inc NRX
Common Stock
|
2014-02-14 | Conversion | 2,148,365 | ||
| showing 20 of 26 most recent transactions | |||||